Linnea Diep

Linnea Diep has a comprehensive work experience in the biotechnology and pharmaceutical industry. Linnea started their career as a Senior Research Associate at CytomX Therapeutics in 2013. Prior to that, they worked as a Research Associate at Genentech in the same year.

Before joining Genentech, Linnea worked at Elan Pharmaceuticals for a significant part of their career. Linnea held the position of Associate Scientist, focusing on Biochemistry and Protein Science. In this role, they purified and characterized antibodies and proteins to support drug discovery projects. Additionally, they delivered high quality proteins for X-ray crystallography, resulting in solving high-resolution structures and identifying compounds for Alzheimer and Parkinson programs.

Later at Elan Pharmaceuticals, they became a Senior Research Associate in Immunochemistry and Biochemistry. During this time, Linnea prepared and delivered enzymatic and recombinant Fab for X-ray crystallography, leading to the publication of high-resolution crystallographic structures in the Journal of Biological Chemistry. Linnea also designed experiments to pegylate Fab for intracerebral injection model study and immunotherapy purposes. Additionally, Linnea implemented barium and iodine stain to identify pegylated proteins.

Overall, Linnea Diep has a strong background in protein science, antibody purification, and X-ray crystallography, with a focus on drug discovery and the study of neurodegenerative diseases like Alzheimer's and Parkinson's.

Linnea Diep obtained a Bachelor's degree in Biology and Chemistry from the University of the Pacific. The specific duration of their studies and any prior education they may have received are not provided.